Kinnate Biopharma Closes $74.5M Series B Financing

Kinnate Biopharma Closes $74.5M Series B Financing New investors OrbiMed, Nextech Invest and Vida Ventures join existing investors Foresite Capital and Eshelman Ventures. Proceeds will be used to advance multiple precision oncology drug candidates into the clinic. SAN...